Hematopoietic cytokines are critically required for survival and cell proliferation of myeloid and erythroid progenitors. It is poorly understood how the apoptotic machinery of progenitor cells senses the absence of speci®c cytokines. Here we show that G1-Cdk activity is essential for cytokine-mediated viability of myeloid and erythroid progenitors. Cytokine deprivation is associated with rapid downregulation of G1-Cdk activity, cell cycle arrest, and apoptosis. Speci®c inhibition of G1-Cdk activity results in apoptotic cell death in the presence of saturating cytokine levels. In contrast, speci®c cell cycle arrest in G2/M does not aect viability. When cell proliferation is arrested by cytokine withdrawal, primary erythroid progenitors expressing v-ErbA maintain G1-Cdk activity and undergo delayed apoptosis. Cdkinhibitors strongly enhance apoptosis in starved v-ErbA cells, indicating that sustained Cdk activity is required for protection from apoptosis by v-ErbA. Oncogene (2001) 20, 4198 ± 4208.
Introduction
Programmed cell death is a fundamentally important biological process required both for normal tissue development (Jacobson et al., 1997) and for maintenance of homeostasis in multicellular organisms (Allen et al., 1993; Hetts, 1998) . Dysregulation of apoptosis may be directly involved in several human diseases, including neurodegenerative disorders, cancer, autoimmune diseases and hematopoietic malignancies (Fisher, 1994; Thompson, 1995; Lotem and Sachs, 1996) .
During normal hematopoiesis, progenitor cells must maintain a delicate balance between cell dierentiation, cell proliferation, and apoptosis (Metcalf, 1989; Martin and Green, 1995; Ra, 1996) . This balance is maintained by a multitude of polypeptide factors including hematopoietic growth factors and cytokines, that regulate hematopoietic development. The critical roles of cytokines in hematopoiesis are to act as survival signals and mitogens (Koury and Bondurant, 1990; Williams et al., 1990; Fairbairn et al., 1993; Wu et al., 1995; Akashi et al., 1997; Lagasse and Weissman, 1997; Maraskovsky et al., 1997) . Consequently, limiting concentrations or complete absence of cytokines cause G1 cell cycle arrest and apoptosis in factordependent hematopoietic progenitors.
The role of cytokines in the regulation of viability is probably most obvious in the case of de®nitive erythropoiesis. Erythropoietin (Epo), the Epo receptor and Jak2 are required for de®nitive hematopoiesis by speci®cally controlling maturation of colony forming unit erythroid (CFU-E) progenitors (Wu et al., 1995 (Wu et al., , 1997 . CFU-E cells represent rapidly dividing, erythroid committed progenitors that are highly responsive to Epo and critically require Epo for both proliferation and survival (Koury and Bondurant, 1990) . Levels of Epo determine the fraction of CFU-E progenitors escaping apoptosis (Kelley et al., 1993) . Ligand-induced dimerization of the Epo receptor leads to activation of its associated kinase Jak2, which is also required for red blood cell production (Neubauer et al., 1998; Parganas et al., 1998) .
Bcl-2 family members (Chao and Korsmeyer, 1998) are potential eectors of cytokine-mediated survival signals. Ectopic expression of antiapoptotic Bcl-2 family members delays apoptosis in cytokine-deprived, immortalized cell lines in vitro (Nunez et al., 1990; Marvel et al., 1994; Chao and Korsmeyer, 1998) and leads to the development of leukemia in the mouse (Vaux et al., 1988; Veis et al., 1993; Traver et al., 1998) . Bcl-X L is essential for hematopoietic development (Motoyama et al., 1995 (Motoyama et al., , 1997 and has recently been shown to be a direct transcriptional target of the Jak2-STAT5 pathway in primary myeloid cells (Kieslinger et al., 2000) and in Friend-virus transformed erythroleukemia cell lines (Socolovsky et al., 1997 (Socolovsky et al., , 1999 . However, in several models including primary erythroid cells, Bcl-X L is not expressed in immature, cytokine-responsive erythroid progenitors, but upregulated only late in erythroid cell maturation (Gregoli and Bondurant, 1997; Gregory et al., 1999) .
In addition to the relative protein levels of pro-and antiapoptotic Bcl-2 family members that are thought to determine cell fate (Chao and Korsmeyer, 1998; Gross et al., 1998; Heiden et al., 1999) , survival factorinduced modi®cations of apoptosis regulators may play important roles. Phosphorylation of Bad (Zha et al., 1996) by the serine/threonine kinase Akt/PKB (Datta et al., 1997) was shown to promote cell survival. However, con¯icting data exist as to the impact of the PI3-kinase/Akt pathway on cytokine-mediated survival of hematopoietic cells (Hinton and Welham, 1999) .
In a variety of model systems, the execution stage of apoptosis is known to be associated with the activation of cellular proteases called caspases (Nicholson and Thornberry, 1997; Ra, 1998; Colussi and Kumar, 1999; Kumar and Colussi, 1999) . Recent work indicates that withdrawal of cytokines, such as Epo or IL-3, results in caspase activation in cytokinedependent hematopoietic cell lineages (Kumar, 1995; Barge et al., 1997; Harvey et al., 1997; Ohta et al., 1997; Antoku et al., 1998) . The molecular mechanisms of caspase activation in cytokine-deprived cells are not well understood and little is known about the precise pathways involved in sensing loss of cytokine signalling in hematopoietic cells.
Likewise, signalling from hematopoietic cytokine receptors to the cell cycle is only partially understood. It has not been rigorously addressed so far, whether or not intracellular cytokine receptor signals required for cell cycle progression are also necessary to protect hematopoietic progenitors from apoptosis. Since cell cyle arrest and cell death induced by cytokine depletion are intimately linked and have not been experimentally uncoupled, we analysed whether there is a role of cell cycle regulatory components in eecting the switch from proliferation to cell death. Here we show that the activity of G1 cyclin/Cdk complexes is essential for viability of factor-dependent hematopoietic progenitors. Conditional expression of the Cdk-inhibitors p16/p27 (Sherr and Roberts, 1999) in the presence of saturating amounts of cytokines induces proteolytic activation of caspase-2 and complete apoptosis. This apoptotic response is indistinguishable from cell death induced by cytokine depletion and can be inhibited by ectopic expression of Bcl-2. Conversely, we show that v-ErbA mediated maintenance of G1-Cdk activity is required for viability in factor-deprived cells.
Results

Kinetics of cell cycle arrest and apoptosis after cytokine withdrawal
The IL3-dependent myeloid progenitor cell line FDCP-1 (Dexter et al., 1980) was used as a model system to analyse the eect of cytokine removal on cell cycle progression and on apoptosis. To rule out the eects of serum factors known to aect these processes, cells were grown in serum-free medium (StemPro 34 2 , supplemented only with IL3; see Materials and methods). After IL3 removal from an exponentially growing culture, the rate of cell proliferation decreased progressively between 7 and 25 h after cytokine removal ( Figure 1a , left panel) and concomitantly cells accumulated in G1 (data not shown). Simultaneously, viability (Trypan blue exclusion) and apoptotic indices (TUNEL assay) were measured in the cytokine depleted cultures. Apoptotic cells rapidly accumulated after a commitment phase of approximately 7 h ( Figure 1a , right panel) and essentially no viable cells could be detected after 35 h.
To address the molecular basis of cell cycle arrest after cytokine withdrawal, we measured protein levels of the various cyclin/Cdk-complex subunits known to be required for G1 progression (Figure 1b, left panels) . Protein levels of the catalytic subunits Cdk2 and Cdk4 did not change signi®cantly within the ®rst 16 h of cytokine depletion. However, the regulatory Cdk2 kinase subunits cyclin A and E disappeared between 7 and 16 h. The Cdk4-associated regulatory subunit cyclin D2 was downregulated with very similar kinetics, while cyclin D1 was not expressed in FDCP-1 cells. Interestingly, cyclin D3 levels were upregulated between 3 and 16 h after cytokine withdrawal, in line with the observation that cyclin D3 persists in postmitotic megakaryocytes . However, upregulation of cyclin D3 did not lead to the formation of active Cdk4/cyclin D3 complexes, since Cdk4 associated Rb kinase activity (Figure 1b , right panel) dropped following 8 h of cytokine removal, similar to Cdk2 associated histone H1 kinase activity ( Figure 1b , right panel). Both Cdk4 and Cdk2 associated kinase activities nearly vanished by 16 h of cytokine depletion. At this time the culture still contained 70% of viable cells. Loss of cyclins E and A appears to be the predominant cause for the drop of histone H1 kinase activity, since protein levels of endogenous Cdk-inhibitors (p15, p16, p18, p19, p21 and p27) are very low in cells grown in the presence of cytokine and do not change signi®cantly after cytokine removal (data not shown). In conclusion, our data indicate that downregulation of Cdk2/cyclinE/A and Cdk4/cyclinD2-associated kinase activities occurs simultaneously to or even precedes proliferation arrest and apoptosis in the cytokine-depleted culture.
Induction of cell cycle arrest causes apoptosis in factor-dependent myeloid and erythroid progenitors Cell survival in non-transformed hematopoietic cells is fully cytokine dependent. We therefore employed the IL3-dependent cell line FDCP-1 to ask if G1-Cdk activity is a crucial requirement for viability in cytokine dependent cells. FDCP-1 cells were stably transfected with a retrovirus-based, tetracyclin-regulated expression system (Paulus et al., 1996) carrying the human Cdk inhibitors p27
Kip1 or p16
INK4a
. The empty vector pBPSTR1 served as a negative control. Infected cells were expanded in the presence of both IL3 and doxycyclin. Individual clones of infected cells were obtained from methocel cultures. To induce expression of Cdk inhibitors and cell cycle arrest, doxycylin was removed from the growth medium in the continuous presence of IL3. Subsequently, aliquots were taken from the cultures to measure DNA pro®les and apoptotic indices using TUNEL assay. p27
Kip1 expressing cells rapidly arrested in the G1 phase of the cell cycle following 25 h of doxycyclin removal (Figure 2b ). Induction of provirally driven p27
Kip1 mRNA expression peaks around 25 h. At this time point endogenous Cdk2-dependent histone H1 activity was essentially undetectable (Figure 2c ). Strikingly, with the accumulation of cells in G1, viability dropped rapidly in the culture. The majority of p27
Kip1 expressing cells died within 50 h of doxycyclin removal ( Figure 2a , left panel). The observed gradual downregulation of ectopically expressed p27
Kip1 mRNA after 25 h is a consequence of the onset of apoptosis. The apoptotic index in the p16
INK4a expressing cells was lower ( Figure  2a , right panel), most likely due to the fact that induction of p16
INK4a and the G1 arrest in these cells was less ecient than in p27
Kip1 expressing cells (data not shown). Using the same conditional induction system we could also demonstrate that p27
Kip1 expression in Epo/SCF dependent erythroid progenitors isolated from p53 7/7 murine fetal livers (von Lindern et al., 2001 ) also induces apoptosis in the presence of cytokines similar to FDCP-1 cells (see Materials and methods, data not shown).
These data suggest that Cdk activity which is required for progression through the G1 phase of the FDCP-1 cells were grown in the presence of 2 ng/ml recombinant murine IL3. For starvation, cells were washed with PBS and reseeded in cytokine-free medium. Cumulative cell numbers were measured to follow the proliferation rate (left panel). Apoptotic indices were measured using the TUNEL assay and viability was determined by trypan blue exclusion (right panel). (b) Left panels: protein levels of the indicated, relevant components of the cell cycle machinery were detected by Western blotting. Only the 34 kD band is shown for murine Cdk2. Right panel: Cell extracts were made at the indicated time points and Cdk2-associated kinase activity was measured using histone H1 as substrate. Similarly, Cdk4-associated kinase activity was determined using GST-Rb as substrate (see Materials and methods). Negative control immunoprecipitates were done with normal rabbit serum (NRS) cell cycle is also necessary for maintenance of viability in cytokine dependent myeloid and erythroid cells.
We next wanted to determine whether induction of apoptosis is speci®cally coupled to the inhibition of G1-cyclin/Cdk complexes or whether general inhibition of the cell division cycle, regardless of the cell cycle stage, is sucient to induce apoptosis. For this purpose, we studied the eects of the synthetic Cdk inhibitor roscovitin on hematopoietic cell viability. Roscovitine speci®cally inhibits Cdk2 associated kinase -mRNA expression after removal of doxycyclin in the clone p274D. Total RNA was isolated from cells at the indicated time points and a respective Northern blot was probed with labelled human p27
Kip1 cDNA (top panel). 28S RNA served as a loading control (middle panel). Cdk2-dependent histone H1 kinase activity from cell lysates was measured at the indicated time points (bottom panel) activity in vitro and in vivo (Alessi et al., 1998) . As a control we used a synthetic inhibitor of polo-like kinases (BI-1511, N Redemann, unpublished) . Pololike kinases are required for cell cycle progression through G2/M (Glover et al., 1998; Mayor et al., 1999) . In pilot experiments the minimal concentration of roscovitine to block cell cycle progression was determined as 20 mM. As expected, treatment of FDCP-1 cells grown in the presence of IL3 with 20 mM roscovitine for 22 h resulted in signi®cant reduction of cells in S-phase and induction of apoptosis (Figure 3a) . More than 90% of cells in the FDCP-1 culture died after 30 h roscovitine treatment, whereas most FDCP-1/Bcl2 cells survived (Figure 3b ). Treatment of FDCP-1 cells with 30 mM PLK inhibitor BI-1511 caused cell cycle arrest in G2/M, however no adverse eect on viability could be detected ( Figure  3a) . Similar results were obtained in the primary celllike p53 7/7 erythroblasts (not shown). Together with the above observations, these data demonstrate that G1-Cdk activity is a prerequisite for viability of hematopoietic progenitors.
Bcl2 delays apoptosis induced by IL3 deprivation or Cdk inhibition
In various established cell lines, ectopic expression of the antiapoptotic Bcl-2-family members has been shown to prevent or delay apoptosis in response to a variety of proapoptotic stimuli, including cytokine deprivation of hematopoietic cells (Nunez et al., 1990) . We have made similar observations using a FDCP-1 line stably expressing ectopic Bcl-2. Removal of IL3 from these cells results in G1 arrest (Figure 4b , left panel). However, no signi®cant apoptosis was detectable either 24 h or 3 days after factor withdrawal ( Figure 4a , black bars). Therefore, we asked whether or not apoptosis induced by expression of ectopic p27 Kip1 could also be inhibited by ectopic expression of Bcl-2. FDCP/Bcl-2 cells grown in the presence of IL3 and doxycyclin were infected with the retrovirus pBPSTR1:p27 and a stable mass culture was obtained after selection with puromycin. To induce expression of p27 Kip1 , doxycyclin was removed from the medium, in the continuous presence of saturating amounts of IL3. After 3 days of doxycyclin withdrawal, the great majority of cells arrested in G1 (Figure 4b , right panel). However, only a minority of the cells became TUNEL positive, the level being much lower (&20%, Figure 4a , grey bars) than in respective p27
Kip1 -expressing cells that were not protected by ectopic Bcl-2 (&70%, compare to Figure 2a ). In conclusion, apoptosis induced by cytokine deprivation or by p27 Kip1 expression in the presence of the cytokine can be similarly delayed by ectopic expression of Bcl-2 in myeloid progenitors.
We recently found maturation/activation of the initiator caspase-2 and eector caspase-3 in FDCP-1 cells deprived of IL3 or induced to express ectopic p27 Kip1 . No other caspases were found activated under either condition including caspases 1, 4, 5, 6, 7, 8, 9, 10 (to be published elsewhere). Therefore we asked whether ectopic Bcl-2 has an eect on activation of initiator caspase-2 under these two dierent experimental conditions. For this, FDCP/Bcl-2 cells were cultured in the absence of IL3 for 3 days, apoptotic cells were separated from viable cells on a Ficoll step gradient (see Materials and methods), and cell extracts from both fractions were subjected to Western blotting using the C-terminal caspase-2 antibody. Signi®cant amounts of the caspase-2 C-terminal p12 subunit of the active enzyme were only detectable in the minor population of apoptotic cells (Ficoll pellet) but not in the viable cells present in the Ficoll interphase ( Figure  4c, left panel) . Likewise, we found activation of (Figure 4c, right panel) . In conclusion, the antiapoptotic function of ectopic Bcl-2 appears to be downstream of a signal generated by loss of G1-Cdk activity and upstream of ecient caspase-2 activation in IL3 deprived cells as well as in cells arrested in the cell cycle due to p27
Kip1 overexpression.
Protection from apoptosis of cytokine-depleted erythroid progenitors by the oncoprotein v-ErbA requires sustained Cdk2 kinase activity
The above results strongly suggest that G1-Cdk activity mediates, at least in part, the survival function of cytokine receptors in hematopoietic cells by prohibiting caspase activation. Maintenance of Cdk2 associated kinase activity in cytokine starved cells should therefore result in prolonged survival. However we were not able to sustain Cdk2 associated kinase activity in starved cells by ectopic expression of cyclins and the catalytic kinase subunit for prolonged time periods (data not shown). This is likely due to the complex regulation of Cdk2 associated kinase activity which requires additional cytokine receptor signals. Nevertheless, we were able to address this question by manipulating endogenous Cdk activity in factordependent, primary cells. We took advantage of the known antiapoptotic activity of the oncoprotein vErbA in primary avian cells (Gandrillon et al., 1994) . . (a) FDCP-1 cells stably transfected with a Bcl-2 expression vector were deprived of IL3 and apoptotic indices were measured by the TUNEL assay at the indicated time points (black bars). FDCP-1/Bcl-2 cells infected with the pBPSTR1:p27 retrovirus were cultured in the absence of doxycyclin but in the presence of IL3 for 3 days and apoptotic indices were measured at indicated time points (grey bars). Data are means+s.e.m. from two independent experiments. (b) DNA pro®les of the two cultures described in (a) show that the majority of cells have accumulated in G1 after 3 days of treatment. (c) Procaspase-2 is only activated in apoptotic cells. FDCP-1/Bcl-2 cells were deprived of IL3 for 3 days (left panel) or FDCP-1/Bcl-2 cells infected with pBPSTR1:p27 retrovirus were grown in the absence of doxycyclin but in the presence of IL3 for 3 days (right panel). Apoptotic cells were separated from viable cells on Ficoll step gradients (see Materials and methods). SDS lysates of equal cell numbers were subjected to Western blotting using a C-terminal caspase-2 antibody. Procaspase-2 processing was only evident in the Ficoll pellet containing the apoptotic cells Accordingly, primary v-ErbA expressing erythroblasts are protected from cell death induced by withdrawal of cytokines required for proliferation of these cells, although they rapidly became growth-arrested (H Beug, unpublished). We therefore asked whether or not v-ErbA would maintain Cdk2 activity in factor deprived cells, and whether Cdk2 activity was required for protection from apoptosis.
Primary avian erythroid progenitors and their retrovirally infected counterparts expressing v-ErbA (Bauer et al., 1998) strictly depend on the c-Kit ligand stem cell factor (SCF), and insulin-like growth factor (IGF-1) for proliferation and (in case of the uninfected cells) for survival (H Beug, unpublished) . Withdrawal of these cytokines induced apoptosis in the two cultures to a dierent extent, as measured using the TUNEL assay. During the early phases of growth factor removal, apoptotic cells accumulated rapidly in the control cell culture, while v-ErbA expressing cells died much more slowly (Figure 5a ). To determine if v-ErbA prevents apoptosis in the absence of cytokines for prolonged time periods, growth factors were removed from both v-ErbA expressing cells and control cells for 72 h. During this time, the proliferation rate decreased with identical kinetics in both cultures, cells becoming completely stationary after 70 h. At this time the entire culture was arrested in G1 as demonstrated by FACS analysis (not shown). Subsequently cells were refed with SCF and IGF-1 and cumulative cell numbers were measured (see Materials and methods). While no cells grew out from the control culture even after prolonged time periods, v-ErbA-expressing cells resumed exponential growth after factor readdition (Figure 5b ). To compare Cdk2 associated kinase activity and apoptosis induction in v-ErbA-expressing versus control erythroblasts, cell lysates were prepared from growth factordeprived cells and Cdk2 dependent histone H1 kinase activity was measured in Cdk2 immunoprecipitates (Figure 5c ). Although both cell types arrested in the G1 phase of the cell cycle with identical kinetics upon factor depletion (not shown), v-ErbA expressing cells maintained histone H1 kinase activity for at least 60 h after factor depletion, whereas kinase activity was lost in control cells between 22 and 46 h. Similarly, cyclin E protein levels remained constant in factor-deprived vErbA erythroblasts whereas they rapidly decreased in control cells, in parallel with histone H1 kinase activity. The sustained cyclin E protein levels in starved v-erbA infected cells must at least in part be due to posttranslational mechanisms since cyclin E mRNA levels decreased with similar kinetics in factor-depleted v-ErbA and control erythroblasts (data not shown).
Using this cell system we could now assess whether or not Cdk2 associated kinase activity was required to mediate protection from apoptosis in factor deprived, cell cycle arrested cells. To inhibit Cdk2 activity in cytokine-depleted v-ErbA-expressing cells the Cdk2 inhibitor roscovitine was added to cultures either at the time of factor removal, or with a delay of 24 h. In either case, the kinetics of apoptosis induction was signi®cantly enhanced in the factor-depleted cultures by addition of the Cdk inhibitor (Figure 5d , left panel, black and grey bars). Inhibition of Cdk activity in the starved culture caused almost complete cell death by 48 h whereas the starved culture without roscovitine still contained 60% of viable cells (Figure 5d , left panel, white bars). In line with the model, that regulation of Cdk activity depends on cytokine signalling and is required for viability, roscovitine also induced apoptosis of v-ErbA expressing cells in the presence of factors (Figure 5d, left panel, striped bars) . In contrast, addition of the PLK inhibitor BI1511, (which inhibits the cell cycle in G2 but does not aect G1 Cdk activity) had no signi®cant eect on the kinetics of cell death (Figure 5d , right panel, stippled bars).
These data demonstrate that Cdk2 kinase activity is required for prolonged survival of factor deprived vErbA expressing primary erythroblasts, even when no longer sucient to sustain cell proliferation because of missing proliferative signals from growth factor receptors.
Discussion
Withdrawal of hematopoietic cytokines has two eects, that have so far been inseparable: cell cycle arrest in G1 and commitment to apoptosis. Using a combination of cell systems that include immortalized myeloid cell lines (IL3-dependent FDCP-1 cells), primary avian erythroid progenitors and immortal, but otherwise primary cell-like murine erythroid progenitors (dependent on Epo/SCF), we demonstrated that cytokine withrawal results in the rapid downregulation of cyclins E and A and concomitant loss of Cdk2-associated kinase activity. The drop of Cdk2-associated kinase activity causes G1 arrest, cessation of cell proliferation, and is accompanied by induction of apoptosis. Strikingly, inhibition of G1-Cdk activity by p27 Kip1 ) or the speci®c Cdk2 inhibitor roscovitine in factor-dependent cells saturated with cytokine resulted in a complete cell survival defect. Importantly, apoptosis speci®cally required G1-Cdk inhibition since a selective block of cell cycle progression at the G2/M boundary caused a complete and reversible proliferation arrest, but did not at all interfere with viability of erythroid and myeloid progenitors.
If inhibition of G1-Cdk kinase activity induces apoptosis in the presence of cytokines, does experimental maintenance of Cdk2 activity delay or prevent apoptosis in the absence of cytokines? In primary avian erythroid progenitors, expression of the oncoprotein vErbA maintains cyclin E protein levels and Cdk2 associated kinase activity after respective growth factors (SCF/IGF1) are withdrawn and cells have ceased to proliferate. This eect is correlated with a strongly delayed onset of apoptosis induction and increased viability after growth factor removal, allowing a signi®cant fraction of starved cells to resume growth after factor restimulation. Interestingly, v-ErbA Figure 5 Prolonged expression of Cdk2-associated kinase activity is required for increased survival of factor deprived v-ErbA expressing primary avian erythroblasts. (a) Primary avian erythroid progenitors infected with a v-ErbA expressing retrovirus (ErbA) and uninfected control cultures (Prim. ebl, see Materials and methods) were deprived of SCF and IGF-1 and loss of viability was followed by the TUNEL assay. (b) Cells were cultured in the absence of SCF and IGF-1 as in (a) for 72 h, until they had completely ceased to proliferate (indicated by arrow). At this time point, the cells were reseeded into complete medium containing SCF and IGF-1 to rescue long term survivors. The reshifted v-ErbA expressing cells (Resh. ErbA) resumed proliferation after factor readdition whereas no surviving cells could be detected in the reshifted primary control culture. (c) Avian Cdk2-associated kinase activity was measured in factor-deprived cell cultures at the indicated time points from Cdk2 immunoprecipitates using histone H1 as a substrate (see Materials and methods). As a negative control normal rabbit serum (NRS) was used. Equivalent amounts of the immunoprecipitates were used for Western blots to determine the relative levels of immunoprecipitated Cdk2. Total cell lysates were used to determine protein levels of avian cyclin E and v-ErbA (see Materials and methods). (d) v-ErbA expressing cells were starved either in the absence of drugs, or the following kinase inhibitors were added as indicated: 20 mM roscovitine at time=0 h, 20 mM roscovitine at time=24 h (left panel, grey bar), or 30 mM PLK inhibitor BI1511 at time=0 h (right panel). Apoptotic cell death in the individual cultures was measured using the TUNEL assay. Data are means+s.e.m. from two independent experiments expression did not delay cell cycle arrest after factor withdrawal (see Figure 5b) . Nevertheless, inhibition of Cdk2 kinase activity in starved v-ErbA expressing cells results in signi®cantly accelerated cell death. Thus, maintenance of Cdk2 kinase activity delays apoptosis in factor deprived cells that no longer progress through the cell cycle. Being able to experimentally uncouple cell cycle block from apoptosis suggests that, at least under certain circumstances, Cdk activity can directly promote cell survival independently of cell cycle progression. Dependence of viability on Cdk activity may ensure that normal progenitor cells do not arrest in G1 as undierentiated and immature cells without concomitant cell death. Absence of apoptosis under limiting cytokine concentrations could severely interfere with normal hematopoietic development or even contribute to development of leukemia (Cortez et al., 1997) . The cytokine-dependent signalling pathways regulating G1 Cdk/cyclin expression or activity, and the potential antiapoptotic targets of Cdk activity in this cell system have not yet been identi®ed.
Our model, that G1-associated Cdk activity mediates at least in part the antiapoptotic eect of hematopoietic cytokines in myeloid and erythroid cells is supported by our ®nding that apoptosis induction by cytokine withdrawal or Cdk inhibition in the presence of cytokine activates the same members of the apoptotic machinery. In either case, caspase-2 activation/cleavage is evident, while we were unable to demonstrate activation of any other known members of the initiator caspase family. In addition, we found consistent activation of the eector caspase 3 in either case (not shown). Interestingly, high levels of both uncleaved initiator caspase-2 and eector caspase-3 are predictors of very poor survival in acute myelogenous leukemia (Estrov et al., 1998) . In contrast, the pattern of caspases induced in myeloid IL3 dependent cells is dierent, when apoptosis is induced by cytotoxic drugs (such as the transcriptional inhibitor ActD) as compared to apoptosis induced by cytokine depletion (Barge et al., 1997) . Thus, our data support a model in which cytokine withdrawal leads to inhibition of G1-Cdk activity, which then triggers apoptotic execution via caspases 2 and 3. A direct prediction of this model would be that physiological and/or unphysiological signals that inhibit G1-Cdk activity of hematopoietic progenitors should lead to a reduction of cell numbers in progenitor pools by apoptosis. This may be the case in some cytostatic treatment regimens used in the clinic, which often severely aect the production of hematopoietic progenitors in the bone marrow.
Finally, we demonstrated that ectopically expressed Bcl-2 strongly delayed apoptotic cell death either induced by cytokine withdrawal or by G1-Cdk inhibition in the presence of cytokines. In either case, the majority of the caspase-2 proenzyme is not processed and presumably inactive. Thus, ectopically expressed Bcl-2 appears to act downstream of à sensing mechanism' which detects lack of G1-Cdk kinase activity and upstream of ecient caspase activation. Despite their importance, the exact molecular role of endogenous Bcl-2 family members in apoptosis of cytokine deprived immature hematopoietic progenitors is still not entirely clear. In particular whether they act upstream of caspase activation, whether they are inhibiting ampli®cation loops of caspase activation or other as yet unknown apoptotic pathways still has to be resolved.
Materials and methods
Cell culture and generation of transiently transfected cells FDCP-1 cells were grown in serum free StemPro34 2 medium (Life Technologies Inc.) containing recombinant murine IL3 (2 ng/ml, Pepro Tech). FDCP-1 cells stably expressing Bcl-2 were a kind gift of Adi Himmler (Boehringer Ingelheim Vienna) and were maintained as the parental IL3 cells. Murine erythroid progenitors (p53 7/7 clone I/11) were isolated in the absence of a detectable senescence phase from fetal livers of p53 7/7 mice and grown in StemPro34 2 medium containing the following factors: human recombinant Epo (2 I.E./ml, Janssen-Cilag Pharma), 100 ng/ml murine SCF (R&D), 40 mg/ml recombinant human IGF-1 (R&D) and 1 mM Dexamethasone (von Lindern et al., 2001) . For cytokine deprivation cells were washed two times with PBS and resuspended in StemPro34 2 medium free of cytokines. Primary avian erythroblasts and their v-ErbA-expressing counterparts were produced and cultivated as previously described (Bauer et al., 1998) .
For separation of apoptotic cells from viable cells 1 ml ®coll (lymphocyte separation medium, Eurobio) was overlaid with 10 ml cell culture medium and centrifuged at 8006g for 10 min. Apoptotic cells were collected in the pellet and viable cells were harvested from the interphase.
Proliferation kinetics
Hematopoietic suspension cell cultures were maintained at a density between 1610 6 and 4610 6 cells/ml by daily medium changes plus readdition of fresh factors with or without appropriate dilution. Growth kinetics was determined by daily cell counting (counting viable and dead cells simultaneously) in an electronic cell counter (CASY-1, SchaÈ rfe System, Germany) and cumulative cell numbers were calculated.
Stable cell lines expressing genes of interest
Stable hematopoietic cell lines in which Cdk activity can be regulated in a conditional manner were constructed as follows. cDNAs encoding the human Cdk inhibitors p16 INK4a and p27
Kip1
were subcloned into the retroviral vector pBPSTR1 (Paulus et al., 1996) according to instructions of the manufacturer (Clontech). Packaging was done in the ecotrophic Phoenix cell line and retroviral infections of hematopoietic cells were performed in the presence of doxycyclin (100 ng/ml) following standard procedures. After puromycin selection for 10 days cells were seeded into StemPro34 2 ± containing Methylcellulose medium (Life Technologies Inc.) in the presence of the required growth factors and doxycyclin for clonal isolation. To induce expression of Cdk inhibitors cells were washed three times in PBS and resuspended in factor-supplemented growth media in the absence of doxycyclin.
Antibodies
The following antibodies were used in this study: cdk2 (M2), cdk4 (C22), cyclinE (M20), cyclinA (C19), cyclinD2 (M20), cyclinD3 (C16), Bcl-2 (C2), caspase-2 p12 (C-20), caspase-3 (H277), all from Santa Cruz Biotech.; anti-cyclinE (06-459, Upstate Biotechn.) to detect avian cyclin E; Bcl-x (B22620, Transduction Labs). For immunoblotting extracts from equal cell numbers were separated on SDS ± PA gels, subjected to semi-dry blotting onto nitrocellulose membranes and processed for detection of proteins by enhanced chemiluminescence (ECL, Amersham) as recommended by the manufacturer.
Immunoprecipitations and kinase assays
Frozen cell pellets (1 ± 2610 7 cells) were resuspended in ice cold lysis buer (50 mM HEPES-KOH pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.1% Tween-20, 10% glycerol, 1 mM NaF, 0.1 mM Na 3 VO 4 , Complete 1 protease inhibitors (Boehringer Mannheim). Cells were homogenized by repeated aspiration through a 27G needle and the extract was cleared by centrifugation at 15000 g for 15 min.
Immunoprecipitations were done using 1 mg cdk2 (M2) to precipitate murine or avian cdk2, or cdk4 (C22) antibodies to precipitate murine cdk4, followed by collection of the immune complexes with protein A sepharose beads (Pharmacia). Kinase assays were performed in 30 ml kinase buer (50 mM HEPES-KOH pH 7.5, 10 mM MgCl 2 , 1 mM DTT, 1 mM NaF, 0.1 mM Na 3 VO 4 ) containing 10 mM ATP, 1 ml g[ 32 P]ATP (10 mCi, 3000 Ci/mmol), 1 mg histone H1 (Boehringer Mannheim) or bacterially expressed GST-Rb (a generous gift from G Hannon, CSHL) at 308C for 15 min. The supernatant of the reactions was incubated with glutathion-sepharose beads for 1 h, beads were washed, boiled in SDS-sample buer and the supernatant was loaded onto a 12% SDS ± PA gel. Subsequently gels were dried and exposed.
Northern blot analysis
Cells were harvested by centrifugation, washed once with PBS and total RNA was prepared using the Quiagen RNeasy kit. Ten micrograms of RNA from each sample were separated on a 1% formaldehyde-agarose gel and transferred to a nylon membrane (Gene Screen, DuPont-NEN). After UV-®xation ®lters were hybridized with a 32 P-labelled probe speci®c for human p27 Kip1 . The hybridized ®lter was washed and exposed to Kodak XOMAT-AR ®lms at 7808C using intensifying screens.
TUNEL assays
Cells (2610 6 ± 5610 6 ) were ®xed in 0.5 ml 4% paraformaldehyde in PBS for 30 min at room temperature and stored in 70% ethanol. Fixation with paraformaldehyde delays the appearance of a sub-2N population in DAPI stained samples. Cell death was measured by washing with PBS and TUNEL reactions were performed using the In Situ Cell Death Detection kit (Boehringer Mannheim). For detection of apoptotic cells labelled with GFP the TUNEL reaction was performed with Cy5-dCTP (Amersham). Cells were washed once with PBS/1% FCS, once with HBS and resuspended in HBS containing 10 mg/ml DAPI (to determine DNA content). Stained cell populations were analysed using a FACS-Vantage (Becton Dickinson): GFP-positive and GFPnegative cells were gated and TUNEL indices and DAPĪ uorescence were measured in both populations. At least 10 000 gated cells were analysed for each time point.
